151 related articles for article (PubMed ID: 29089195)
1. Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes.
Landi A; Law J; Hockman D; Logan M; Crawford K; Chen C; Kundu J; Ebensen T; Guzman CA; Deschatelets L; Krishnan L; Tyrrell DLJ; Houghton M
Vaccine; 2017 Dec; 35(50):6949-6956. PubMed ID: 29089195
[TBL] [Abstract][Full Text] [Related]
2. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
Chmielewska AM; Naddeo M; Capone S; Ammendola V; Hu K; Meredith L; Verhoye L; Rychlowska M; Rappuoli R; Ulmer JB; Colloca S; Nicosia A; Cortese R; Leroux-Roels G; Balfe P; Bienkowska-Szewczyk K; Meuleman P; McKeating JA; Folgori A
J Virol; 2014 May; 88(10):5502-10. PubMed ID: 24599994
[TBL] [Abstract][Full Text] [Related]
3. Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization.
Wong JA; Bhat R; Hockman D; Logan M; Chen C; Levin A; Frey SE; Belshe RB; Tyrrell DL; Law JL; Houghton M
J Virol; 2014 Dec; 88(24):14278-88. PubMed ID: 25275133
[TBL] [Abstract][Full Text] [Related]
4. Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.
Logan M; Law J; Wong JAJ; Hockman D; Landi A; Chen C; Crawford K; Kundu J; Baldwin L; Johnson J; Dahiya A; LaChance G; Marcotrigiano J; Law M; Foung S; Tyrrell L; Houghton M
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795422
[TBL] [Abstract][Full Text] [Related]
5. Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5.
Lin Y; Kwon T; Polo J; Zhu YF; Coates S; Crawford K; Dong C; Wininger M; Hall J; Selby M; Coit D; Medina-Selby A; McCoin C; Ng P; Drane D; Chien D; Han J; Vajdy M; Houghton M
J Virol; 2008 Aug; 82(15):7492-503. PubMed ID: 18508900
[TBL] [Abstract][Full Text] [Related]
6. Induction of humoral and cellular immune responses against hepatitis C virus by vaccination with replicon particles derived from Sindbis-like virus XJ-160.
Zhu W; Fu J; Lu J; Deng Y; Wang H; Wei Y; Deng L; Tan W; Liang G
Arch Virol; 2013 May; 158(5):1013-9. PubMed ID: 23250650
[TBL] [Abstract][Full Text] [Related]
7. The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization.
Ebensen T; Delandre S; Prochnow B; Guzmán CA; Schulze K
Front Cell Infect Microbiol; 2019; 9():31. PubMed ID: 30838180
[TBL] [Abstract][Full Text] [Related]
8. N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses.
Ren Y; Min YQ; Liu M; Chi L; Zhao P; Zhang XL
Biochim Biophys Acta; 2016 Aug; 1860(8):1764-75. PubMed ID: 26278021
[TBL] [Abstract][Full Text] [Related]
9. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and functional characterization of Leishmania-derived hepatitis C virus envelope glycoprotein complex.
Grzyb K; Czarnota A; Brzozowska A; Cieślik A; Rąbalski Ł; Tyborowska J; Bieńkowska-Szewczyk K
Sci Rep; 2016 Aug; 6():30627. PubMed ID: 27481352
[TBL] [Abstract][Full Text] [Related]
11. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.
Huret C; Desjardins D; Miyalou M; Levacher B; Amadoudji Zin M; Bonduelle O; Combadière B; Dalba C; Klatzmann D; Bellier B
Vaccine; 2013 Mar; 31(11):1540-7. PubMed ID: 22634300
[TBL] [Abstract][Full Text] [Related]
12. Broadly neutralizing immune responses against hepatitis C virus induced by vectored measles viruses and a recombinant envelope protein booster.
Reyes-del Valle J; de la Fuente C; Turner MA; Springfeld C; Apte-Sengupta S; Frenzke ME; Forest A; Whidby J; Marcotrigiano J; Rice CM; Cattaneo R
J Virol; 2012 Nov; 86(21):11558-66. PubMed ID: 22896607
[TBL] [Abstract][Full Text] [Related]
13. Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists.
Christiansen D; Earnest-Silveira L; Chua B; Boo I; Drummer HE; Grubor-Bauk B; Gowans EJ; Jackson DC; Torresi J
Viral Immunol; 2018 May; 31(4):338-343. PubMed ID: 29489437
[TBL] [Abstract][Full Text] [Related]
14. Identification of GLA/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits.
Heeke DS; Lin R; Rao E; Woo JC; McCarthy MP; Marshall JD
Vaccine; 2016 May; 34(23):2562-9. PubMed ID: 27085175
[TBL] [Abstract][Full Text] [Related]
15. Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.
Polakos NK; Drane D; Cox J; Ng P; Selby MJ; Chien D; O'Hagan DT; Houghton M; Paliard X
J Immunol; 2001 Mar; 166(5):3589-98. PubMed ID: 11207320
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses.
Vajdy M; Selby M; Medina-Selby A; Coit D; Hall J; Tandeske L; Chien D; Hu C; Rosa D; Singh M; Kazzaz J; Nguyen S; Coates S; Ng P; Abrignani S; Lin YL; Houghton M; O'Hagan DT
J Gen Virol; 2006 Aug; 87(Pt 8):2253-2262. PubMed ID: 16847121
[TBL] [Abstract][Full Text] [Related]
17. Induction of humoural and cellular immunity by immunisation with HCV particle vaccine in a non-human primate model.
Yokokawa H; Higashino A; Suzuki S; Moriyama M; Nakamura N; Suzuki T; Suzuki R; Ishii K; Kobiyama K; Ishii KJ; Wakita T; Akari H; Kato T
Gut; 2018 Feb; 67(2):372-379. PubMed ID: 27797937
[TBL] [Abstract][Full Text] [Related]
18. Local innate responses and protective immunity after intradermal immunization with bovine viral diarrhea virus E2 protein formulated with a combination adjuvant in cattle.
Sadat SMA; Snider M; Garg R; Brownlie R; van Drunen Littel-van den Hurk S
Vaccine; 2017 Jun; 35(27):3466-3473. PubMed ID: 28527686
[TBL] [Abstract][Full Text] [Related]
19. Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins.
Ray R; Meyer K; Banerjee A; Basu A; Coates S; Abrignani S; Houghton M; Frey SE; Belshe RB
J Infect Dis; 2010 Sep; 202(6):862-6. PubMed ID: 20677942
[TBL] [Abstract][Full Text] [Related]
20. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
